Your browser doesn't support javascript.
loading
miR-542 inhibits tumorigenesis and chemoresistance through the AKT/NFκB pathway in cervical cancer.
Liu, Q H; Li, H L; Zhang, H; Li, Z; Zhao, M; Zhang, T T.
Affiliation
  • Liu QH; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Li HL; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Zhang H; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Li Z; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Zhao M; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Zhang TT; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
J Biol Regul Homeost Agents ; 34(5): 1809-1817, 2020.
Article in En | MEDLINE | ID: mdl-33153258
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / MicroRNAs Limits: Female / Humans Language: En Journal: J Biol Regul Homeost Agents Journal subject: BIOLOGIA / BIOQUIMICA Year: 2020 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / MicroRNAs Limits: Female / Humans Language: En Journal: J Biol Regul Homeost Agents Journal subject: BIOLOGIA / BIOQUIMICA Year: 2020 Document type: Article Affiliation country: China